Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD Moderna, Inc. Transaction History

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD

$397 Million
Q4 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$63.64 - $125.14 $1.62 Million - $3.19 Million	25,484 Added 135.1%	44,347 $2.96 Million
Q2 2024 Jul 29, 2024	SELL	$101.21 - $166.61 $1.35 Million - $2.22 Million	-13,325 Reduced 41.4%	18,863 $2.24 Million
Q3 2023 Nov 06, 2023	BUY	$96.41 - $126.61 $294,243 - $386,413	3,052 Added 10.48%	32,188 $3.32 Million
Q2 2023 Jul 25, 2023	BUY	$118.5 - $160.53 $1.51 Million - $2.04 Million	12,727 Added 77.56%	29,136 $3.54 Million
Q1 2023 May 08, 2023	BUY	$135.66 - $197.02 $2.23 Million - $3.23 Million	16,409 New	16,409 $2.52 Million

Others Institutions Holding MRNA

# of Institutions

904

Shares Held

235M

Call Options Held

10.4M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $12.1B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD, based on Form 13F filings with the SEC.

News

Stay updated on Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD with notifications on news.

Account